Clinical Trial Update: Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating inhibition of plaque formation in subjects with a gingival index ≤1.5 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gingivitis

Snippet

Sponsor: Schülke & Mayr GmbH | Conditions: Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5) | Phase 3 | Status: COMPLETED